HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ongoing Dossier Updates Seen As Big REACH For Industry – Study

This article was originally published in The Rose Sheet

Executive Summary

The requirement for registrants to update REACH chemical dossiers when changes occur or new information comes to light represents an endless road, and many companies are running out of gas, suggests a third-party report commissioned by ECHA. Moreover, there's confusion about what needs to be updated, when, and who is responsible, the authors say, extending recommendations for improvements.

You may also be interested in...



ECHA: Current REACH Registrations Could Fail New Completeness Check Coming In April

The European Chemicals Agency will implement an updated completeness check process in April for dossiers submitted under REACH. The revised check will extend to chemical safety reports, the agency says, noting that dossiers previously submitted successfully may not pass muster now.

REACH Phase-In Registration Is Over. Now What?

After 10 years and nearly 90,000 registrations, the phase-in period for existing chemicals under the EU’s REACH regulation is finished. New chemicals must continue to be registered, and substance dossiers have to kept up to date through ongoing cooperation between registrants, ECHA reminds industry.

California DTSC's Alternatives Analysis Guide Version 1.0 Slated For Public Discussion

The cosmetics industry has yet to be affected by California's Safer Consumer Products regulation, but if a cosmetic product/chemical combination is included in the next round of Priority Product selections, companies will have the DTSC's heavily criticized – and largely unchanged – Alternatives Analysis Guide to steer their compliance efforts.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121185

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel